Search
News & Opinion
Magazine
Current Issue
Archives
Features
Infographics
Top 10 Innovations
Subjects
Cancer Biology
Careers
Cell & Molecular Biology
Clinical Research
Coronavirus
Disease & Medicine
Ecology & Environment
Evolution
Genetics & Genomics
History
Immunology
Microbiology
Neuroscience
Obituaries
Paleontology
Pharma & Biotech
Policy
Profile
Publishing
Research Integrity
Techniques
Multimedia
Infographics
Image of the Day
Crossword Puzzles
Videos
Research Resources
Webinars
The Scientist University
eBooks
Podcasts
Infographics
Videos
Subscribe
Bristol-Myers Squibb to Buy Celgene for $74 Billion
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Home
Subjects
celgene
celgene
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Katarina Zimmer | Jan 22, 2018
Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.